Statins and Pulmonary Fibrosis: The Potential Role of NLRP3 Inflammasome Activation

Rationale: The role of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins) in the development or progression of interstitial lung disease (ILD) is controversial. Objectives: To evaluate the association between statin use and ILD. Methods: We used regression analyses to evaluate the...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Xu, Jin-Fu, Washko, George R., Nakahira, Kiichi, Hatabu, Hiroto, Patel, Avignat S., Fernandez, Isis E., Nishino, Mizuki, Okajima, Yuka, Yamashiro, Tsuneo, Ross, James C., San José Estépar, Raúl, Diaz, Alejandro A., Li, Hui-Ping, Qu, Jie-Ming, Himes, Blanca E., Come, Carolyn E., D'Aco, Katherine, Martinez, Fernando J., Han, MeiLan K., Lynch, David A., Crapo, James D., Morse, Danielle, Ryter, Stefan W., Silverman, Edwin K., Rosas, Ivan O., Choi, Augustine M. K., Hunninghake, Gary M.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Thoracic Society 2012
Materias:
Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3297101/
https://ncbi.nlm.nih.gov/pubmed/22246178
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1164/rccm.201108-1574OC
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares